Camelot Portfolios, LLC BCAT — BLACKROCK CAP ALLOCATION TER

Ownership history in Camelot Portfolios, LLC  ·  14 quarters on record

AI Ownership Summary

Camelot Portfolios, LLC reported BLACKROCK CAP ALLOCATION TER (BCAT) in 14 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.38% in 2024 Q1. The latest visible filing shows BCAT at 0.17% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this BCAT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Camelot Portfolios, LLC's position in BLACKROCK CAP ALLOCATION TER, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

BCAT was reported at 0.17% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.38% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

BCAT stock page Camelot Portfolios, LLC fund profile Camelot Portfolios, LLC full holdings
How Camelot Portfolios, LLC held BCAT — position size vs. price
% of Fund (quarterly)    BCAT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED — — — 19,500 — 0% 0.17% $276K 2026-02-14 (Est.) $14.44
2025 Q3 UNCHANGED — — — 19,500 — 0% 0.17% $288K 2025-11-17 $12.93
2025 Q2 UNCHANGED — — — 19,500 — 0% 0.18% $295K 2025-07-17 $12.61
2025 Q1 ADDED — — — 19,500 +1,000 +5.4% 0.17% $281K 2025-05-13 $12.30
2024 Q4 REDUCED 21.3% +0.5% ❌ 18,500 -5,000 -21.3% 0.30% $280K 2025-02-03 $11.73
2024 Q3 REDUCED — — — 23,500 -1,000 -4.1% 0.38% $387K 2024-11-12 $11.73
2024 Q2 ADDED — — — 24,500 +1,000 +4.3% 0.23% $402K 2024-08-12 $11.08
2024 Q1 REDUCED — — — 23,500 -1,000 -4.1% 0.38% $392K 2024-05-08 $10.52
2023 Q4 ADDED — — — 24,500 +1,000 +4.3% 0.22% $366K 2024-01-23 $9.73
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding BCAT

As of 2026 Q1 — sorted by position size

WINEBRENNER CAPITAL MANAGEMENT LLC 0.37% Formidable Asset Management, LLC 3Y 7Y 0.14% EVOLVE PRIVATE WEALTH, LLC 0.07% PFG Investments, LLC 0.06% Amplius Wealth Advisors, LLC 3Y 0.04% EAGLE ROCK INVESTMENT COMPANY, LLC 3Y 0.04% Walkner Condon Financial Advisors LLC 3Y 0.03% Patriot Financial Group Insurance Agency, LLC 3Y 7Y 0.03% SeaCrest Wealth Management, LLC 3Y 7Y 0.02% KINGSWOOD WEALTH ADVISORS, LLC 0.02%

FAQ About Camelot Portfolios, LLC and BCAT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Camelot Portfolios, LLC reported owning BCAT?

Camelot Portfolios, LLC reported BCAT across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported BCAT position in Camelot Portfolios, LLC's portfolio?

The largest reported portfolio weight for BCAT was 0.38% in 2024 Q1.

What is the latest reported BCAT position on this page?

The most recent filing on this page is 2025 Q4, when Camelot Portfolios, LLC reported 19,500 shares, equal to 0.17% of portfolio, with an estimated market value of $276K.

What does the chart on this BCAT ownership page compare?

The chart compares Camelot Portfolios, LLC's quarterly BCAT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Camelot Portfolios, LLC time their BCAT position?

Based on 13F filing dates vs. subsequent BCAT price moves, Camelot Portfolios, LLC correctly timed 6 out of 9 reported position changes (67%). The annualised alpha on BCAT relative to SPY over the holding period was -1.7%.

← Back to Camelot Portfolios, LLC Holdings